Important: This page is for informational purposes only, based on published peer-reviewed research and official UK dietary guidelines (NHS, EFSA, SACN). It does not constitute medical advice. Always consult your GP or pharmacist before starting, stopping, or combining supplements.
Iron and Vitamin E — Can You Take Them Together?
Overview
Iron and vitamin E are two nutrients commonly supplemented by UK adults — iron to address deficiency and support energy metabolism, and vitamin E for its role as a lipid-soluble antioxidant. Research suggests these two supplements may interfere when taken simultaneously, particularly when inorganic iron forms such as ferrous sulfate are used. Ferrous iron has a documented capacity to catalyse oxidative reactions within the gastrointestinal tract, which may reduce vitamin E bioavailability. This interaction is considered moderate in severity and is most relevant at therapeutic supplemental doses. Choosing an appropriate iron form and spacing supplementation carefully may help minimise potential interference.
How They Interact
At the biochemical level, ferrous iron (Fe²⁺) participates in Fenton-type reactions within the gastrointestinal lumen. In the presence of hydrogen peroxide — a byproduct of normal intestinal metabolism — the reaction proceeds: Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻, generating highly reactive hydroxyl radicals. Alpha-tocopherol, the predominant circulating form of vitamin E in humans, is a lipid-soluble antioxidant that is particularly susceptible to radical-mediated oxidation. Research by Liebler and Burr (1992, PMID 1326326) demonstrated that iron-catalysed lipid peroxidation converts alpha-tocopherol into alpha-tocopheryl quinone — a biologically inactive metabolite — via electron-transfer reactions of the intermediate tocopheroxyl radical. This mechanism is most pronounced with inorganic iron salts such as ferrous sulfate, where the iron ion is relatively unbound and free to engage in redox chemistry. Chelated iron forms, such as ferrous bisglycinate, are coordinated with amino acid ligands that restrict free ionic iron availability, potentially reducing pro-oxidant activity in the gut. The extent of any interaction is influenced by supplemental dose, gastric pH, co-ingested food, and the broader antioxidant milieu of the gastrointestinal environment.
Timing & Dosage Guidance
Research supports separating iron and vitamin E supplementation by a minimum of two to four hours to reduce potential oxidative interference in the gut lumen. As vitamin E is fat-soluble, absorption is enhanced when taken alongside a meal containing dietary fat; a lunchtime or evening dose is practical for most people. Iron supplementation — particularly as ferrous sulfate — is often recommended on an empty stomach to maximise uptake, though this can increase gastrointestinal discomfort in some individuals. A straightforward approach is to take iron first thing in the morning, away from other supplements, and vitamin E with a fat-containing meal later in the day. Individual responses may vary, and those taking prescribed therapeutic doses of iron should discuss supplementation timing with an NHS healthcare professional or registered dietitian.
The UK Scientific Advisory Committee on Nutrition (SACN) sets reference nutrient intakes for iron at 8.7 mg per day for adult men and post-menopausal women, and 14.8 mg per day for women aged 19–50. Therapeutic iron doses prescribed for iron-deficiency anaemia typically range from 100–200 mg elemental iron per day — substantially exceeding dietary reference values — and are more likely to generate a meaningful oxidative burden within the gut. A prospective study (PMID 20888091) found that 100 mg per day of ferrous sulfate over 100 days significantly reduced serum vitamin E in anaemic women, suggesting this dose range is clinically relevant. For vitamin E, SACN references 4 mg per day for men and 3 mg per day for women; however, common supplement doses of 67–268 mg (100–400 IU) d-alpha-tocopherol considerably exceed these thresholds. At high supplemental doses of both nutrients, the potential for interaction is proportionally greater, making iron form selection and separation timing more important considerations. Individual responses may vary.
Recommended Action
If taking both, separating them by a few hours or using a chelated iron form (ferrous bisglycinate) may reduce the interaction.
Iron Timing
When: Morning
Note: Best absorbed on an empty stomach with Vitamin C. Avoid with tea, coffee, calcium, or zinc within 2 hours.
Vitamin E Timing
When: Morning
Note: Fat-soluble — take with a meal containing dietary fat. High doses may increase bleeding risk.
Scientific Evidence
4 peer-reviewed studies cited. All links lead to PubMed abstracts.
Biochemistry (1992) · PMID: 1326326
Iron-catalysed lipid peroxidation converts alpha-tocopherol to its quinone form via tocopheroxyl radical intermediates, providing direct mechanistic evidence that reactive iron species deplete biologically active vitamin E.
Journal of the American Society of Nephrology (2000) · PMID: 10703678
A single oral dose of 1200 IU alpha-tocopherol before intravenous iron administration significantly reduced lipid peroxidation markers in haemodialysis patients, demonstrating clinically relevant antioxidant antagonism between high-dose iron and vitamin E.
Clinical Nutrition (2011) · PMID: 20888091
Women taking 100 mg per day of ferrous sulfate for 100 days showed significantly decreased serum alpha-tocopherol alongside elevated lipid peroxidation markers, despite improved haemoglobin, indicating that therapeutic iron supplementation depletes circulating vitamin E.
Journal of Pediatric Gastroenterology and Nutrition (2016) · PMID: 27548249
In a randomised controlled trial, co-administration of vitamin E with therapeutic iron in iron-deficient infants did not impair iron repletion efficacy, suggesting that protective antioxidant co-supplementation is feasible without compromising treatment outcomes.
Frequently Asked Questions
Research suggests this is plausible, particularly at therapeutic doses of inorganic iron. A prospective study (Ülger et al., 2011; PMID 20888091) found that women taking 100 mg per day of ferrous sulfate showed significant reductions in serum antioxidant vitamins including alpha-tocopherol. The effect appears dose-dependent and more pronounced with inorganic iron salts. Switching to chelated forms and spacing supplementation may reduce this risk. Individual responses may vary based on diet, baseline antioxidant status, and gut environment.
Evidence suggests chelated iron forms such as ferrous bisglycinate are less likely to interfere with vitamin E than inorganic salts like ferrous sulfate. The amino acid chelate restricts free ionic iron, reducing its capacity to drive Fenton-type oxidative reactions in the gut. Whilst head-to-head human trials specifically measuring vitamin E levels across iron forms remain limited, mechanistic evidence and comparative bioavailability research support this view. Those concerned about the interaction may wish to discuss switching iron forms with a healthcare professional or NHS dietitian.
Multivitamins typically provide iron and vitamin E at levels closer to dietary reference intakes — considerably lower than therapeutic supplemental doses. At these amounts, the interaction is unlikely to be clinically significant for most people. However, for individuals prescribed high-dose therapeutic iron for iron-deficiency anaemia, adding a separate high-dose vitamin E supplement may amplify the concern. Research suggests separating supplementation by a few hours is a practical, low-risk precaution regardless of form or dose.
Top Iron Products on AIScored
Top Vitamin E Products on AIScored
Advanced Hydrolysed Marine Liquid Collagen Couples Supply (2x 28-Day Supply)
Want to check more interactions?
Add these and other supplements to our interactive Stack Analyzer for a full analysis.
Build your full stack →